Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$129.86 - $157.03 $212,970 - $257,529
-1,640 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$122.87 - $139.12 $10,566 - $11,964
86 Added 5.53%
1,640 $215,000
Q2 2021

Aug 12, 2021

BUY
$128.08 - $145.09 $199,036 - $225,469
1,554 New
1,554 $214,000
Q1 2020

May 12, 2020

SELL
$39.81 - $112.01 $86,387 - $243,061
-2,170 Closed
0 $0
Q4 2019

Jan 24, 2020

BUY
$93.31 - $116.55 $202,482 - $252,913
2,170 New
2,170 $243,000
Q4 2018

Jan 25, 2019

SELL
$57.41 - $79.06 $325,342 - $448,033
-5,667 Closed
0 $0
Q3 2018

Oct 17, 2018

BUY
$73.09 - $81.64 $414,201 - $462,653
5,667 New
5,667 $459,000
Q2 2018

Jul 27, 2018

SELL
$61.34 - $76.43 $575,062 - $716,531
-9,375 Closed
0 $0
Q1 2018

Apr 06, 2018

BUY
$50.61 - $64.53 $474,468 - $604,968
9,375 New
9,375 $594,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $1.86B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.